Daily Stock List
Capital Group Holdings, Inc. (CGHC)
StockBomb.com, StockLockandLoad, StockRockandRoll, MomentumOTC, PennyStockLocks.com, and Winston Small Cap reported recently on Capital Group Holdings, Inc. (CGHC), and we are highlighting the Company as "One to Watch" this week here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Capital Group Holdings, Inc. is an acquirer and operator of fundamentally sound companies that are market accepted, scalable and demonstrate a quantifiable value proposition. The Company's focus is Health and Wellness organizations that have a strong market presence, brand awareness, and talented and dedicated management teams with the potential to achieve outstanding performance over time. Capital Group Holdings has their corporate headquarters in Scottsdale, Arizona.
Currently, the Company operates two wholly owned subsidiaries: OneHealthPass, Inc., and OneHealth Urgent Care, Inc. Capital Group Holdings lends their operational support, management approach and financial resources to these companies to achieve improvements in profit and positioning in the marketplace. Capital Group Holdings, by way of their subsidiaries, presently operates seven urgent care clinics (OneHealth™ Urgent Care, OneHealth™ UC) in metropolitan Phoenix, Arizona. The Company is now researching and developing their telemedicine services via their subsidiary OneHealthPass (OHP).
The Company's customers can reach a physician at any time, can access basic medical services, and have the ability to receive sound medical advice and treatment for the most common minor medical issues. Capital Group Holdings' network of independent board-certified doctors may provide, at their discretion, prescriptions for treatment that can be retrieved immediately at the member's local pharmacy. If a member needs to be examined in person, they can be examined at one of the Company's local urgent care clinics, or be referred elsewhere.
OneHealth™ Urgent Care's traditional formula for opening clinics is to locate new clinic in cities with high ER volume, strong demographics, and busy primary care physicians. OneHealth™ Urgent Care clinics provide walk-in, extended hour access for acute illness and injury care.
Their customers' experience an average service time (check-in to checkout) less than 40 minutes versus more than four hours, on average, for ER wait times. This is better than the industry average. The cost of an urgent care visit is one-sixth the cost of an ER visit. OneHealth™ Urgent Care provides care on a walk-in basis between 8 am and 8 pm.
Recently, Capital Group Holdings announced that their Board of Directors determined that material expansion opportunities exist to increase the number of urgent care clinics of OneHealth Urgent Care (OHUC). The Company's intention is to expand their OneHealth footprint at first within Arizona and subsequently expand to neighboring states. All OHUC clinics are open seven days a week. They are equipped with state of the art digital radiography (x-ray) and have on-site phlebotomy services.
We have Capital Group Holdings, Inc. (CGHC) locked on our radar screens as "One to Watch" this week here at the QualityStocks Daily Newsletter.
Capital Group Holdings, Inc. (CGHC), closed Monday's trading session at $0.09, down 18.92%, on 50,150 volume with 14 trades. The average volume for the last 60 days is 126,559 and the stock's 52-week low/high is $0.0038/$0.42.
Clean Coal Technologies, Inc. (CCTC)
PennyTrader Publisher, OTCJournal, and Greenbackers reported previously on Clean Coal Technologies, Inc. (CCTC), and we are highlighting the Company as "One to Watch" this week here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Clean Coal Technologies, Inc. holds patented process technology and other intellectual property (IP) that converts raw coal into a cleaner burning fuel. Their trademarked products, "Pristine™" coals (Pristine™ and Pristine-M™), are substantially more efficient, less polluting, more cost-effective, and provide more heat than untreated coal. Clean Coal Technologies is based in New York, New York.
Use of the Company's innovative process makes possible the upgrade of low-rank coals, including lignite, into premium fuels that are high in calorific content and low in pollutants. The basis of the principal elements of their pre combustion technology is on well-proven science and tried-and-tested industrial components.
Their clean coal technology may reduce approximately 90 percent of chemical pollutants from coal, including Sulfur and Mercury. As a result, this would resolve emissions issues affecting coal-fired power plants. Clean Coal Technologies' process does not involve pulverization and subsequent briquetting of the coal. The Company's "Vapor Phase Deposition" process allows for the increase of the calorific content of the raw coal beyond what would be achieved naturally by the removal of moisture alone.
Clean Coal Technologies is working with Science Applications International Corp. (SAIC) on the construction of a 1:15 scale pilot plant. The plant will undergo testing at the site of a major U.S coal-fired power company in the State of Oklahoma. The pilot plant is on track for commissioning this year.
In February 2013, Clean Coal Technologies announced that they signed a new EPC Agreement with Science Applications International Corp. (SAIC). They also remitted the first payment of $2 million to SAIC for the construction of the 2-ton/hour pilot plant in Oklahoma, as per the terms of the new contract. As sole counterparty to the new EPC contract, Clean Coal Technologies has assumed the obligations for the project under the contract; they will own the completed pilot plant outright.
Today, Clean Coal Technologies announced that the Company has retained Carrier Vibrating Equipment, Inc. to design and build a batch processor that adds capabilities to the pilot test plant that Clean Coal Technologies plans to commission in the August to September period of this year. Carrier, headquartered in Louisville, Kentucky, is a major supplier to the pilot plant that has been designed and will be built by SAIC.
We have Clean Coal Technologies, Inc. (CCTC) in our sightlines as "One to Watch" this week here at the QualityStocks Daily Newsletter.
Clean Coal Technologies, Inc. (CCTC), closed Monday's trading session at $0.04, up 9.59%, on 9,485,894 volume with 366 trades. The average volume for the last 60 days is 607,688 and the stock's 52-week low/high is $0.035/$0.074.
Generex Biotechnology Corp. (GNBT)
OTCPicks, PennyTrader Publisher, and Greenbackers reported earlier on Generex Biotechnology Corp. (GNBT), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Trading on the OTC Markets' OTCQB, Generex Biotechnology Corp. engages in the research, development, and commercialization of drug delivery systems and technologies. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity - with no deposit in the lungs. Generex Biotechnology has their headquarters in Toronto, Ontario.
Generex Biotechnology's proprietary liquid formulations allow drugs normally administered by injection to undergo absorption into the body through the lining of the inner mouth using their proprietary RapidMist™ device. The Company's buccal insulin spray product, Generex Oral-lyn™, is in Phase III clinical trials at a number of sites worldwide.
Antigen Express, Inc. is a wholly owned subsidiary of Generex Biotechnology. Antigen Express is a platform technology and product-based company. This subsidiary is developing proprietary vaccine formulations for active immunotherapy and disease prevention. The core platform technologies of Antigen Express consist of immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, as well as autoimmune diseases.
Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One technology focuses on modification of peptides with Ii-Key to increase potency. A second technology relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for powerful stimulation of T-helper cells and prevents the further growth of cancer cells.
Generex Biotechnology is positioned to move ahead with their clinical and regulatory programs and corporate plans. Generex is actively seeking prospective partners for the Phase III trial of the Antigen Express AE37 breast cancer vaccine. Antigen Express is preparing to seek a Special Protocol Assessment (SPA) for the trial. An SPA is a declaration from the Food and Drug Administration (FDA) that the trial's design, clinical endpoints, and statistical analyses are acceptable for FDA approval.
Last week, Generex Biotechnology highlighted the advantages of their AE37 cancer vaccine and technology in the context of a positive cancer immunotherapy forecast recently issued by Citigroup analysts. Their subsidiary Antigen Express is currently in a late Phase IIb trial of the novel cancer vaccine AE37 to prevent relapse in patients who have had breast cancer.
According to Reuters, in a report issued on May 22, 2013, Mr. Andrew Baum, head of global healthcare research at investment bank Citi, forecasts that in a decade immunotherapy cancer drugs will be treating 60 percent of cancers and generate yearly sales of equal to $35 billion. This analysis highlights cancer immunotherapy as the next "big thing" in biopharmaceutical research.
Generex Biotechnology Corp. (GNBT), closed Monday's trading session at $0.0384, up 5.21%, on 11,916,270 volume with 478 trades. The average volume for the last 60 days is 2,072,857 and the stock's 52-week low/high is $0.0205/$0.115.
Ucore Rare Metals, Inc. (UURAF)
Today we are reporting on Ucore Rare Metals, Inc. (UURAF), here at the QualityStocks Daily Newsletter.
Trading on the OTCQX International, Ucore Rare Metals, Inc. is concentrating on establishing rare metal resources with near term production potential. The Company has multiple projects across North America. Their principal focus is the 100 percent owned Bokan-Dotson Ridge Rare Earth Element (REE) property in Alaska. Ucore Rare Metals has their corporate headquarters in Bedford, Nova Scotia.
Rare Earths include the unique elemental suite called the Rare Earth Elements (REE‘s) and a select group of specialty metals produced mainly for technology applications. REE's are non-toxic elements. They are essential to obtaining a cleaner environment with reduced reliance on fossil fuels.
The Bokan-Dotson Ridge REE project is 60 kilometers southwest of Ketchikan, Alaska and 140 kilometers northwest of Prince Rupert, British Columbia (B.C.). The project has direct ocean access to the western seaboard and the Pacific Rim. The Bokan-Dotson Ridge property is the subject of a Preliminary Economic Assessment (PEA) that underwent preparation by Tetra Tech of Vancouver, B.C. (Preliminary Economic Assessment on the Bokan Mountain Rare Earth Element Project, Near Ketchikan, Alaska, dated March 4, 2013).
The Bokan Mountain project encompasses 30 square kilometers (19 square miles). The Bokan property is specifically enriched with heavy rare earth elements; these include the vital elements Dysprosium, Terbium and Yttrium. Approximately 40 percent (by weight) of the rare earth elements contained on the Dotson Ridge property are heavy rare earths elements (disclosed in Ucore's NI 43-101 compliant resource estimate, released in March 2011).
The Company's other projects include Ray Mountains, Alaska; Lost Pond, Newfoundland; extensive claims throughout Western Newfoundland and in Labrador, as well as Sandybeach Lake, Nunavut.
In April of this year, Ucore Rare Metals reported on the passage of Senate Joint Resolution No. 8 by the State of Alaska Legislature. All 39 representatives in attendance voted in favor of the Resolution. The Resolution states the Legislature's support for continued and increased exploration, extraction, processing and production of rare earth elements in Alaska.
Last month, Ucore Rare Metals announced that the Company has completed the equity offering earlier announced on March 15, 2013, in the full amount for gross proceeds of $5,000,000. Ucore's intention is to use the net proceeds of the Offering to progress the development of the Bokan Mountain-Dotson Ridge property as well as for general working capital purposes.
Ucore Rare Metals, Inc. (UURAF), closed Monday's trading session at $0.2565, up 15.54%, on 278,245 volume with 40 trades. The average volume for the last 60 days is 104,648 and the stock's 52-week low/high is $0.211/$0.6448.
MyECheck, Inc. (MYEC)
PennyStocks411 reported today on MyECheck, Inc. (MYEC), PennyStocks24, Penny Stock Rumble, The Stock Wrangler, WallstreetSurfers, Mega Penny Stock Pick, Orbit Stocks, MarketWireStocks, RockingPennyStocks, fusionspicks did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Pink Current Information, MyECheck, Inc. is a leading electronic transaction data processor. The Company provides an alternative payment solution to paper checks, cards or Automated Clearing House (ACH) payments. MyECheck is the leader in Check 21 solutions and check image processing for online and mobile transactions. They provide merchants with financial access to more customers and faster funds clearing than any other payment method. Founded in 2004 (on the day Check 21 legislation became law), MyECheck has their corporate headquarters in El Dorado Hills, California.
The Company makes use of a patented method of clearing check data for very fast, secure and cost effective payments. MyECheck operates under license to US Patent 7,389,913 Method and Apparatus for Online Check Processing issued June 2008. MyECheck is the sole licensee of US Patent No. 7,389,913.
MyECheck offers all-inclusive and easily implemented solutions that enable real-time payments by authorized fully electronic check. Their electronic check service creates and clears checks using only customer account data. The Company's system enables more payers - any authorized signor on any US checking account, for any amount. MyECheck works with every US checking account, even accounts that Automated Clearing House (ACH) e-check solutions cannot debit. MyECheck's transactions can be payment guaranteed. MyECheck offers a Check Authorization Service and a Check Guarantee Service.
In April, MyECheck announced an agreement with Karmen Consultants Group. MyECheck will provide back-end check data processing services that will significantly enhance Karmen's Payment Processing and Payroll Card Platforms. This includes enabling more users and faster clearing of funds. Karmen Consultants Group is a leading provider of Corporate Payroll Processing and Tax and Bill Payment Solutions. The expectation is that the agreement will generate approximately $500,000 in yearly revenue for MyECheck.
Moreover, in April, MyECheck announced that they will license their proprietary system to other operators for a share of their transaction revenue on the system. The Company has patent sub-licensing rights that they currently intend to exploit. MyECheck has also developed, and operates, the worlds first and most robust electronic check engine, replications of which are now undergoing licensing to other companies.
MyECheck, Inc. (MYEC), closed Monday's trading session at $0.0031, even for the day, on 10,738,214 volume with 63 trades. The average volume for the last 60 days is 23,450,017 and the stock's 52-week low/high is $0.0001/$1.00.
International Commercial Television, Inc. (ICTL)
MoneyTV reported recently on International Commercial Television, Inc. (ICTL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, International Commercial Television, Inc. is a worldwide consumer products company with corporate headquarters in Wayne, Pennsylvania. The Company markets innovative and effective products in clearly defined market segments predominantly health and beauty, fitness and leisure sports, and children's products. International Commercial Television's goal is to create enduring shelf brands that result in a solid base business while continually testing and marketing new unique products.
Currently, the Company sells products via infomercials. However, the objective of their business plan is to use the brand awareness they create in their infomercials so that they can sell the products featured in their infomercials, along with related families of products, under distinct brand names in traditional retail stores. Their goal is to have these families of products sold in the traditional retail environment in shelf-space dedicated to the product category. International Commercial Television is developing the infrastructure to create these brands of products so that they can implement their business plan.
International Commercial Television has distribution channels in place in more than 35 countries. They use a distinctive marketing strategy and multi-channel distribution model to develop, market, and sell their products. Marketing and distribution of their products is done through infomercials, live home shopping television, specialty outlets, online shopping, and other forms of distribution.
In April, the Company announced a licensing agreement entered into with DermaNew, Inc. International Commercial Television will obtain the exclusive global rights to manufacture and distribute their latest patented anti-aging and re-surfacing scientific skincare system. The system consists of an innovative skincare device and a collection of associated topical formulas (both patented). Beauty experts, Dean Rhoades and Amby Longhofer, own and operate DermaNew.
Last month, International Commercial Television filed their first quarter Form 10-Q for the three months ended March 31, 2013. Financial highlights for the first quarter of 2013 include Revenues increasing by 367 percent to $12,400,233. This is in comparison to $2,655,311 in the first quarter of 2012. Gross margin percentage improved by 9 percent to 72 percent. This is up from 63 percent for the same period the year prior.
Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) were $1,514,553. This is in comparison to $96,191 for the first quarter of 2012. Net Income for the period was $1,168,559, versus a Net Loss of $21,608 for the same period in 2012.
International Commercial Television, Inc. (ICTL), closed Monday's trading session at $0.59, even for the day, on 74,500 volume with 15 trades. The average volume for the last 60 days is 30,084 and the stock's 52-week low/high is $0.0812/$0.85.
Oromin Explorations Ltd. (OLEPF)
Vantage Wire, FeedBlitz, and SmallCapVoice reported previously on Oromin Explorations Ltd. (OLEPF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Oromin Explorations Ltd. is a growth-oriented resource company whose shares trade on the OTC Markets' OTCQB. The Company is focusing on exploring the OJVG Gold project in Senegal, West Africa. The OJVG Golouma Gold Project is an advanced stage low risk, construction ready gold project. Oromin Explorations has their headquarters in Vancouver, British Columbia.
Oromin (43.5 percent) and their partners, Bendon International
(43.5 percent) and Badr Investments (13 percent) earlier formed Somigol, the Sénégalese operating company. Somigol owns 100 percent of the project subject to a 10 percent carried interest held by the government of Sénégal. Oromin Explorations is the project operator.
The total indicated resource for all deposits at the Project is 75.21 million tonnes grading 1.56 g/t Au containing 3.78 million ounces of gold. The total inferred resource for all deposits at the Project is 17.33 million tonnes grading 1.73 g/t Au, containing 0.96 million ounces of gold. The Project's current Probable Reserve, as set out in the 2013 CIL Feasibility Study, is 2.34 million ounces (28 MT grading 2.59 g/t Au).
In late March of this year, Oromin Explorations, on behalf of Oromin Joint Venture Group (OJVG), announced that the NI 43-101 Technical Report "OJVG Golouma Gold Project Updated Preliminary Economic Assessment of the Heap Leach Potential" (PEA) underwent filing on SEDAR.
Selected highlights of the Heap Leach PEA update include that the proposed heap leach operation provides an opportunity to capture value from lower grade resources on the project. Highlights also include that the average annual heap leach gold production for the first full three years of production is 36,000 ounces per year at a $760 operating cash cost per ounce.
The average annual life of mine (LOM) heap leach gold production is 27,000 ounces per year at an operating cash cost of $929 per ounce.
A number of open pit gold deposits will provide a heap leach production period of just over 14 years. All of the heap leach deposits remain open to expansion. A minimum of 14 additional exploration prospects may further enhance the Project's future resource base.
Oromin Explorations Ltd. (OLEPF), closed Monday's trading session at $0.3565, up 42.83%, on 366,769 volume with 72 trades. The average volume for the last 60 days is 30,478 and the stock's 52-week low/high is $0.2266/$0.858.
Dephasium Corp. (DPHS)
Today we are reporting on Dephasium Corp. (DPHS), here at the QualityStocks Daily Newsletter.
Dephasium Corp. recently acquired the U.S. Ancilia trademark and patent from Dephasium, Ltd. The Company's intention is the commercialization of that product. Dephasium plans to become the leader in the field of people protection against electromagnetic waves emitted by mobile phones. Dephasium has their headquarters in Miami, Florida. The Company's shares trade on the OTC Markets' OTCQB.
Recently, Dephasium announced that the Company has appointed a new President and Director. Mr. J. Francisco Terreforte was appointed to fill a position on the Board of Directors. Additionally, Mr. Terreforte was appointed President and Secretary of the Registrant. Mr. Terreforte previously held these positions with the Company.
Last week, Dephasium announced that they entered into an agreement to retain DesignIRFirm as their investor relations and capital markets firm to advise and support Dephasium with their investor communications and marketing efforts. This is with a specific concentration on building their investor relations strategy. DesignIRFirm is a California-based investor relations firm. They provide investor relations, business development and capital markets advice and support to primarily OTC-listed companies.
Today, Dephasium confirmed that they completed the acquisition of the Ancilia patent and trademark, Registration Number 4,085,620 (the Assets). In return for the Assets, Dephasium issued to Dephasium, Ltd., a United Kingdom limited partnership, 70,000,000 shares of their restricted common stock. The Company valued the acquisition of the assets at $1.2 million.
Dephasium Ltd. has succeeded in developing an Ancilia product that they believe protects up to 98 percent of electromagnetic waves issued by cell phones. The basis of this conclusion is upon the results of technology tests administered by Cetecom ICT Services and included in their written report dated August 10, 2009.
Mr. J. Francisco Terreforte, President of the Company, in making this announcement, said, “We are very excited about the acquisition of the technology and we are looking forward to working with our counterparts across the Atlantic Ocean to sell these products in the United States and Canada.”
Dephasium Corp. (DPHS), closed Monday's trading session at $0.5901, up 21.67%, on 3,153,728 volume with 802 trades. The average volume for the last 60 days is 10,733 and the stock's 52-week low/high is $0.10/$0.55.
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.46, up 58.62%, on 2,181,923 volume with 566 trades. The stock’s average daily volume over the past 60 days is 160,100, and its 52-week low/high is $0.21/$1.25.
The Aristocrat Group Corp. was pleased to report today that the company, along with its brand management division, Luxuria Brands, see ideal market conditions for launching a new, high-end distilled spirit in the U.S. right now and are anticipating big results from the show-stopping rollout of their debut vodka this summer. A gluten-free vodka made from 100% Idaho russet potatoes and distilled in the U.S. by master distillers at Distilled Resources Inc., RWB Ultra-Premium Handcrafted Vodka is set to blow the doors off the domestic spirits market, which soared from $13.9B in 2003 to $21.3B last year.
The Aristocrat Group Corp. (ASCC) is a brand management company focused on providing premiere luxury goods through continual innovation. Luxuria Brands, a subsidiary of The Aristocrat Group, has been established to identify and promote unique brands that have mass market appeal across a diverse demographic.
Luxuria Brands is primarily concentrated on distilled spirits industries, with an initial focus on Vodka branding and marketing. The worldwide distilled spirits market is currently worth about $263 billion. In the U.S. alone, Vodka sales between 2004 and 2009 grew 25% from 13.9 million cases to 58.4 million cases. The clear liquor now accounts for almost a third of all distilled spirits consumed and continues to rise in popularity.
The Aristocrat Group is also pursuing opportunities in the women’s lifestyle industry. The World Bank recently estimated that the earning power of women will reach $18 trillion by 2014, which is twice the estimated 2014 GDP of China and India combined. The Aristocrat Group is working to bring fresh, innovative prenatal and postpartum solutions to women who are looking for a more comprehensive approach to wellness.
The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. The company aims to take a leadership position in multiple growing markets that offer opportunities for partnership, sponsorship, and brand awareness activities. The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Declares Market Conditions Ideal for Upcoming Vodka Launch
ASCC Formulates Plans to Capitalize on Successful Vodka Launch
ASCC Unveils Debut Spirits Brand RWB Vodka
Solar Wind Energy Tower, Inc. (SWET)
The QualityStocks Daily Newsletter would like to spotlight Solar Wind Energy Tower, Inc. (SWET). Today, Solar Wind Energy Tower, Inc. closed trading at $0.026, even with yesterday's close, on 713,942 volume with 17 trades. The stock’s average daily volume over the past 60 days is 772,266, and its 52-week low/high is $0.01/$0.08.
Solar Wind Energy Tower, Inc. was announced today by QualityStocks as having dropped a new audio interview on markets, with President and CEO of SWET, Ronald W. Pickett, providing a comprehensive overview of the company's revolutionary Solar Wind Downdraft Tower. This new interview looking at the technology's ability to harness dry heat, solar rays, and water to produce energy, creating a cost-effective solution that overcomes the limitations experienced by other alternative energy sources, is available at (http://dtg.fm/SWET-Interview-06-13).
Solar Wind Energy Tower, Inc. (SWET) is focused on commercializing a number of proven, validated technologies and construction systems into a single large Solar Wind Downdraft Tower structure that produces abundant, inexpensive electricity. The company's core objective is to become a leading provider of clean, efficient energy at a reasonable cost, while continuing to generate innovative technological solutions for tomorrow's electrical power needs.
The company's cutting-edge energy solution generates clean energy by harnessing the natural power of a downdraft created within the confines of a Solar Wind Downdraft Tower structure. Using benevolent, non-toxic natural elements, the solar/wind hybrid technology is capable of being operated with virtually no carbon footprint, fuel consumption, or waste production. To view a demonstration of the tower, visit http://dtg.fm/4Gp7.
The business plan employed by Solar Wind Energy includes partnering with various entities, such as utilities, sovereign nations, and independent power sources, to bring this solution to the market as rapidly as possible. The company's role would consist of facilitating the Tower's development with its expertise and intellectual property. Revenue streams include development fees, licensing fees, and royalties on power sales from each project and/or ownership interests.
Solar Wind Energy has assembled a team of experienced business professionals, as well as engineering and scientific consultants, with the proven ability to bring new ideas to market. The company has also filed and been issued patents that protect its revolutionary technology and leading position in the continual global pursuit to meet rising demand for energy. Disclaimer
Solar Wind Energy Tower, Inc. Company Blog
Solar Wind Energy Tower, Inc. News:
Solar Wind Energy Tower, Inc. CEO Featured in Exclusive QualityStocks Interview
Solar Wind Energy Tower, Inc. Receives Notice of Allowance of Patent titled "Atmospheric Energy Extraction Devices and Methods"
Solar Wind Energy Tower, Inc. Partners with Commonwealth Dynamics, Inc.
Raptor Resources Holdings Inc. (RRHI)
The QualityStocks Daily Newsletter would like to spotlight Raptor Resources Holdings Inc. (RRHI). Today, The Aristocrat Group Corp. closed trading at $0.022, up 76.00%, on 10,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 78,215, and its 52-week low/high is $0.0002/$0.0395.
Raptor Resources Holdings Inc. (RRHI) is a publicly traded holdings company focused on mineral resource acquisition, exploration, and development. The company currently has two subsidiaries: Mabwe Minerals Inc. (MBMI), a natural resources and hard asset company engaged in the mining and commercial sales of industrial minerals & metals with first focus on barite; and TAG Minerals Inc., a mineral & metal resource acquisition, exploration, and development company with first focus on alluvial surface gold.
Mabwe Minerals has been the focus of the parent company’s efforts the last two years to move into commercial barite production. RRHI shareholders share a common interest with MBMI shareholders in the success of Dodge Mine as the parent company owns 90M shares of MBMI. The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc.
TAG Minerals, along with its indigenous affiliate, TAG Minerals Zimbabwe (Private) Limited, is responsible for alluvial gold production along with the development of greenfield assets targeting bedrock gold and other potential metals & minerals. As MBMI is transitioning into commercial barite production, RRHI will now focus on building assets within TAG Minerals with the intent of moving into commercial production within the next 18 months. TAG Minerals will utilize the latest in Heavy Particle Concentrators (HPC-30/HPC-100) through its relationship with Extrac-TEC whose gold recovery and mineral separation technology captures up to 98% of alluvial gold down to 50 microns. The company is in early stage exploration evaluating potential alluvial sites to ensure they meet the company's criteria for commercial production. Coupled with MBMI's acquisition of WGB Kinsey & Company, TAG Minerals is well positioned to fast track into commercial production once the company has successfully completed its exploratory testing.
RRHI management continues to improve its balance sheet as reflected in the company's SEC 10k filing, including favorable reductions in the company's debt/liabilities and securing 54.4M shares and 14.4M warrants of RRHI from prior employees. The company is committed to growing its asset base in TAG Minerals moving forward. Disclaimer
Raptor Resources Holdings Inc. Company Blog
Raptor Resources Holdings Inc. News:
Mabwe Minerals Shareholder Report Card
Raptor Resources Holdings Files SEC Form 10-K, Annual Report
Rafarma Pharmaceuticals, Inc. (RAFA)
The QualityStocks Daily Newsletter would like to spotlight Rafarma Pharmaceuticals, Inc. (RAFA). Today, Rafarma Pharmaceuticals, Inc. closed trading at $0.18, up 51.26%, on 365,336 volume with 47 trades. The stock’s average daily volume over the past 60 days is 17,145, and its 52-week low/high is $0.041/$0.98.
Rafarma Pharmaceuticals, Inc. (RAFA) is a multiproduct pharmaceutical company specializing in the production of generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. Rafarma stands as one of the most ambitious projects in recent medical history, having constructed the most technologically advanced pharmaceutical plant in Russia.
Based in Terbuny, Lipetsk region, Russia, Rafarma possesses a unique niche in the burgeoning pharmaceutical market and is poised to become a major player in the international drug industry. The company was established under the auspices of the Foundation to Support Health Care and has been approved by the Ministry of Health.
Rafarma recently received the general license for pharmaceutical products and began manufacturing three new products: Sodium Para-Aminosalicilate, Ibuprofen, and Betagistin. Receiving the general license was one of the final steps the company needed to open its new plant in Terbuniv, and Rafarma has been named one of only four national strategic pharmaceutical suppliers to the Russian Federation.
Advances in health care science, medicine, and technology have increased the general life expectancy of Eastern European citizens steadily over the past decade. Elderly citizens, which comprise the largest portion of the pharmaceuticals market, have bolstered demand for pharmaceuticals nationwide. Rafarma is well positioned to capitalize on the expanding industry with its strong relationships and state-of-the-art production facility. Disclaimer
Rafarma Pharmaceuticals, Inc. Company Blog
Rafarma Pharmaceuticals, Inc. News:
Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
Rafarma Pharmaceuticals Registers CEFTRIAXONE Under International Label
Rafarma Pharmaceuticals, Inc. Receives General License for Pharmaceutical Products and has Started to Manufacture 3 New Products
The Aristocrat Group, via brand management division, Luxuria Brands, is preparing to debut its new vodka line, RWB Ultra-Premium Handcrafted Vodka. The Aristocrat Group today acknowledged favorable conditions in the market for high-end distilled spirits in the United States.
In the last 10 years, U.S. spirits revenue has increased to $21.3 billion from revenues of $13.9 billion in 2003. Both revenue and volume jumped to significant gains in 2012 as consumer trends shifted toward interest and preference of top-shelf products. Super premium spirits rose in volume by 8.9 percent last year, according to the Distilled Spirits Council (DISCUS).
With greater relation specifically to vodka, the company reports that gross revenues for vodka grew by more than 5 percent in the U.S. last year to nearly $5.5 billion.
The Aristocrat Group is entering a particular niche with its new gluten-free, ultra-premiumvodka that the company will release later this summer. The company says that RWB Vodka will be one of only a handful of spirits in the U.S. that meets the necessary requirements to feature the words “gluten-free” on its label and packaging.
For more information visit www.aristocratgroupcorp.com
Solar Wind Energy Tower is the developer of a single large Solar Wind Downdraft Tower structure that produces renewable, cost-effective electricity without the restraints other alternative energies may face. Company CEO Ronald W. Pickett was recently featured in an audio interview with QualityStocks in which he provides a sweeping review of the company’s technology and applications to the energy industry.
The interview can be heard at http://dtg.fm/SWET-Interview-06-13.
In the interview, Pickett discusses the capabilities of the company’s Solar Wind Downdraft Tower, how its structure has evolved, as well as supporting patents. He also details current and potential projects with facilities around the world, strategic partnerships, and an outlook for the remainder of 2013.
“The best thing about our approach is that we’re going to make electricity in a totally clean manner, zero-carbon footprint, renewable, abundant and predictable. But the key is we’re going to make it at a price that’s affordable and comparable with traditional energy manufacturing,” Pickett says in the interview.
Solar Wind Energy’s technology, as the name suggests, utilizes dry heat, solar rays, and water to produce energy, creating a renewable energy solution that overcomes the limitations experienced by other alternative energy sources.
For more information visit www.solarwindenergytower.com
Advaxis, Inc., a clinical-stage biotechcompany developing the next generation of immunotherapies for cancer and infectious diseases, Sunday reported conclusive 12-month overall survival and additional data from Lm-LLO-E7-15, a randomized phase 2 study evaluating the safety and efficacy of ADXS-HPV +/- cisplatin in patients with recurrent cervical cancer.
As of May 17, 2013, the trial had completed enrollment and 110 patients have received 264 doses of ADXS-HPV (ADXS11-001). The company reported that final 12-month overall survival is 36 percent with a current 18-month survival of 22 percent. Thesedata compare to data from the last update at 33 percent and 17 percent, respectively, and are the best results yet reported for this study.
Among other data, median overall survival was approximately 8.5 months – patients who have completed the study will continue to be followed for survival. In addition, subset analyses showed that the addition of cisplatin to ADXS-HPV did not significantly improve survival or tumor response in this study.
“These data suggest that ADXS-HPV has the potential to become a non-chemotherapy treatment option capable of improving survival for women with cervical cancer. Clinical benefit was evident in this trial even in women with cancer that recurred aggressively, who had bulky metastatic tumors, and who had been previously treated with both chemotherapy and radiotherapy. The side effects reported by less than half of the patients were mild, and associated primarily with the infusion. Furthermore, the ability of ADXS-HPV in this study to cause durable complete and partial remission of solid tumors as a monotherapy, is very promising,” stated Dr. Petit.
Thomas A. Moore, chairman and CEO of Advaxis, said that in light of the favorable data, the company’s focus will be to advance ADXS-HPV to registrational status.
“These results have stood up very well, both over time and in our new, detailed analysis. We believe the promising clinical benefits and attractive side effect profile shown in the data collected about ADXS-HPV thus far make this potentially a whole new class of therapy in this disease. Advaxis will progress ADXS-HPV to registrational trials as quickly as possible, exploring additional dosing that may further extend any clinical benefits.”
The data were presented by Dr. Robert Petit, chief scientific officer at Advaxis, at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, on Sunday.
For more information visit www.advaxis.com
Cloud technology has exploded upon the world relatively recently, being increasingly accepted as a fundamental shift in the way that the power of computer processing and associated communications can be used. Various forms of cloud processing have begun to work their way into almost every industry, making it hard to consider the notion, also being increasingly accepted, that the term “cloud computing” could, in the not too distant future, effectively vanish. The disappearance of the term may or may not actually happen, but there seems to be little doubt that processing power and processed data will eventually become so completely decentralized as to make specific reference to the technology largely unnecessary.
The evolution is not unlike that of microcomputers, the integration of the processing and memory aspects of a computer onto a single microprocessor chip, making possible the small personal computers that created a global industry and changed our industrialized lifestyle. The technology is so common and pervasive today that the the term microcomputer, popular in the 1970s and 1980s, is now seldom used.
The potential of cloud technology to redefine the way we work with information is no less foundational. Already, cloud technology is revolutionizing the information user experience, driving the sale of tablets and other on-the-go devices. Although we still tend to depend upon keyboards for heavy volume input, interfaces will no doubt change, providing even greater user flexibility and mobility. Imagine a world where, through some hyper-advanced combination of cloud and device technologies, being connected to a world of processing power and information is as easy as putting on a shirt, with no keyboards, no screens, no speakers, and yet complete and instant input and output of all types whenever and wherever needed.
GlobalWise Investments and its Intellinetics subsidiary represent the beginning of that evolution. The company offers Intellivue, a sophisticated ECM (Enterprise Content Management) system that allows any organization to integrate document management and access capabilities with their existing systems. Most importantly, it can be used in a cloud-based configuration that provides secured access to company documents on a 24/7 basis from anywhere in the world. The idea is that the user won’t even have to think about the technology behind the capability, but will simply have all of the answers whenever and wherever needed.
For information on GlobalWise and its subsidiary Intellinetics, visit www.GlobalWiseInvestments.com and www.Intellinetics.com.
Today's Top 3
Penny Stocks Profile
Penny Stock Newsletter
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Survival and New Analysis for ADXS-HPV in Patients with Recurrent Cervical Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Announces Generx Publication In Molecular Therapy
- DoMark International, Inc. (DOMK) Develops New Product for $2.3 Billion iPad Accessories Market
- GNCC Capital, Inc. (GNCP) Reaches Agreement to Acquire White Hills Gold Properties
- GlobalWise Investments, Inc. (GWIV) Adds Toshiba Business Solutions AZ/CO as New Channel Sales Partner
- International Stem Cell Corp. (ISCO) Initiates IND-Enabling Study in Parkinson's Disease Program
- Loans4Less.com, Inc. (LFLS) CEOCFO Magazine Interview Highlights Solid Market Position
- Low Carbon Technologies International, Inc. (LWCTF) Plans to Announce 6 Month YTD Financials
- Mabwe Minerals Inc. (MBMI) Announces Engagement of QualityStocks Investor Relations Services
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) to Drive Growth Through Personalized Medicine
- Raptor Resources Holdings Inc. (RRHI) Mabwe Minerals Shareholder Report Card
- Solar Wind Energy Tower, Inc. (SWET) CEO Featured in Exclusive QualityStocks Interview
- StreamTrack, Inc. (STTK) Announces Alliance to Potentially Reach Over 300 Million Registered PPTV Users
- The Aristocrat Group Corp. (ASCC) Declares Market Conditions Ideal for Upcoming Vodka Launch
- The Guitammer Company Inc. (GTMM) Goes Supersonic!
- VentriPoint Diagnostics Ltd. (VPTDF) Announces New Vice-President of Sales and Marketing
- VistaGen Therapeutics, Inc. (VSTA) and Duke University Publish Results on Production of Functional 3D Human Heart Tissue